CBRN
Identified CBRN agent
Chemical
CBRN event in Russian Federation on Sat 26th October 2002
26th October 2002
Russian doctors treating hostages for the inhalation of the gas deployed during the Moscow theatre siege are using an antidote supplied by the Russian military for a rare form of nerve agent developed in the 1970s, according to chemical warfare experts. Clumsy use of the mysterious nerve agent caused the deaths of at least 115 hostages in addition to disabling most of the 50 Chechen hostage-takers.
The antidote being used is for the group of nerve agents related to the gas BZ, developed by the US military in the 1970s. BZ is a "glycolate" which attacks the central nervous system. It was developed by the US Department of Defence and is considered non-lethal if applied correctly.
Russian authorities initially refused to name the gas that killed the hostages, leading to complaints that it was making their job of treating patients with antidotes much harder. Yet chemical warfare experts told the Guardian that Moscow doctors had been given an antidote by the Russian military for a rare nerve agent developed by the US military, called BZ. Professor Steven Rose, of the Open University, said a Russian counterpart had told him that doctors had been supplied the antidote from a military stockpile.
Contextual analysis
Analysing the event count by highlighting the presence of munition categories over a six-month data period.
Understand the complete picture with an Enterprise account.
Learn moreSign in to view this information
Information sources
Discussion and media of this event has been extracted from all sources.
Sign in to view this information
Country information
Click to view more information about the country and see more information on conflicts occuring in that region.
Russian Federation (RUS)
Discover more
Events using similar munitions or platforms and those that happen within a recent time line and proximity are displayed below.
Understand the complete picture with an Enterprise account.
Learn moreSign in to view this information